HCV therapy can reverse, slow, or stop fibrosis
- NATAP - www.natap.org
Impact of pegylated interferon alfa-2b and ribavirin on liver
fibrosis in patients with chronic hepatitis C - study published in
by Thierry Poynard et al
Study finds that HCV therapy can reverse, slow, or stop fibrosis &
inflammation progression even for viral nonresponders. And, 50% of
patients with cirrhosis were able to improve liver disease/fibrosis,
viral responders did better. An editorial in Gastroenterology was
written by Prof. Michael Arthur saying that...if you think cirrhosis
is impossible.....this study may change your mind....there is
substantial evidence that in human liver disease & animals liver
fibrosis & cirrhosis can regress over time, depending in part on
whether or not the underlying cause is persistent.
Do you Yahoo!?
The New Yahoo! Search - Faster. Easier. Bingo.